Gene expression of connective tissue growth factor in relation to nephropathy in patients with type 2 diabetes

Regulatory Role of Long Non-Coding RNA “Maternally-Expressed Gene-3” in Diabetic Nephropathy through Targeting microRNA-21 and Transforming Growth Factor-Beta

MicroRNA-377 Expression Level as a Marker of Nephropathy in Type 2 Diabetes Mellitus

Molecular Evaluation of Long Non-Coding RNA (TUG1) in Systemic Lupus Erythematosus

Microrna 192 Gene Expression in Type II Diabetic Nephropathy

MALAT1 Gene Expression in Diabetic Patients with or without Nephropathy

Association Between Interlukin 10 Gene Polymorphism And Susceptibility To Diabetic Kidney Disease

Study The Association between Serum Osteoprotegerin and Diabetic Kidney Disease

MicroRNA29-a as Diabetic Nephropathy Biomarker in Diabetic Patients (Type 2)

Increased LncRNA TUG1 expression level impacted ankylosing spondylitis risk, association with disability, and patients’ quality of life